Malaria afflicts 212 million people globally and kills approximately 429,000.*
In 2001 Bloomberg Philanthropies gave $100 million to the Bloomberg School to fund a state-of-the-art research facility that would mount a broad program of basic-science research to treat and control malaria, develop a vaccine and find new drug targets to prevent and cure this deadly disease.
The Johns Hopkins Malaria Research Institute (JHMRI) started operations in the Bloomberg School's W. Harry Feinstone Department of Molecular Microbiology and Immunology in May 2001. The JHMRI was soon able to attract a critical mass of malaria experts from around the world. Together they are taking a multidisciplinary approach to understanding the Plasmodium parasite, the mosquito and the genes and proteins involved in the transmission of malaria.
Learn more with our PDF presentation, JHMRI Resources.
*World Health Organization, World Malaria Report 2016